{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Chicago",
      "state": "IL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "88619",
      "recalling_firm": "Meitheal Pharmaceuticals Inc",
      "address_1": "8700 W Bryn Mawr Ave Ste 600",
      "address_2": "N/A",
      "postal_code": "60631-3512",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the USA and India",
      "recall_number": "D-0801-2021",
      "product_description": "Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21",
      "product_quantity": "1,160 ten-pack cartons",
      "reason_for_recall": "Failed Impurities/Degradation Specifications",
      "recall_initiation_date": "20210903",
      "center_classification_date": "20210915",
      "termination_date": "20240512",
      "report_date": "20210922",
      "code_info": "Lot #: G0010120, Exp. Date December 2021; G0080520, Exp. Date April 2022; G0090221, G0100221, Exp. Date January 2023",
      "more_code_info": ""
    }
  ]
}